What does this video actually claim?
The TikTok from @raenahealth makes several assertions about women's hormones versus men's testosterone treatment. It claims men's low testosterone gets taken seriously while women's symptoms are dismissed as normal aging.
The video argues that symptoms like sleep problems, mood swings, belly fat, and feeling unlike yourself are actually caused by declining progesterone levels. It suggests progesterone affects the nervous system and stress response, making these symptoms legitimate medical concerns rather than inevitable aging.
The creator appears to be setting up a comparison about gender bias in hormone treatment, though the video cuts off mid-sentence.
Is there a gender bias in hormone treatment?
The claim about differential treatment has some merit, though it's more complicated than presented. A 2019 systematic review by Clayton and Arnegard in Biology of Sex Differences found that women's cardiovascular symptoms are often misattributed to anxiety or stress.
However, testosterone replacement isn't universally embraced either. The American College of Physicians' 2020 guidelines recommend against routine testosterone therapy for men over 65, citing limited benefits and potential cardiovascular risks.
Women's hormone therapy faces scrutiny too, partly due to the Women's Health Initiative findings that showed increased stroke and breast cancer risks with certain hormone combinations. The landscape isn't as simple as "men get treatment, women get dismissed."
Does progesterone really cause these symptoms?
This is where the science gets mixed. Progesterone does decline during perimenopause, typically starting in a woman's 40s. The SWAN study (Study of Women's Health Across the Nation) tracked this decline over 15 years in over 3,000 women.
Sleep disruption has the strongest evidence. A 2018 study in Sleep Medicine Reviews by Kravitz et al. found that progesterone's metabolite, allopregnanolone, acts on GABA receptors to promote sleep. When progesterone drops, sleep quality often suffers.
The mood and stress claims are shakier. While progesterone affects neurotransmitters, the relationship isn't straightforward. A 2017 randomized trial by Gordon et al. in Menopause found that progesterone therapy didn't significantly improve mood symptoms compared to placebo.
What about the belly fat connection?
Here's where @raenahealth stretches the evidence. The video implies declining progesterone directly causes "stubborn belly fat," but that's not well-established.
Weight gain during menopause is real. The SWAN study showed women gain an average of 1.5 pounds per year during the menopausal transition. But this relates more to estrogen decline and metabolic changes than specifically progesterone.
A 2012 study in Climacteric by Davis et al. found that estrogen therapy, not progesterone, was associated with less visceral fat accumulation in postmenopausal women. The progesterone-belly fat link isn't supported by quality evidence.
Should women consider progesterone therapy?
The answer depends on specific symptoms and individual risk factors. For sleep issues related to perimenopause, there's reasonable evidence that progesterone might help.
The North American Menopause Society's 2022 position statement supports progesterone use for sleep disturbances in perimenopausal women. Typical dosing ranges from 100-200mg of micronized progesterone taken at bedtime.
But progesterone isn't risk-free. It can cause drowsiness, dizziness, and mood changes in some women. The video's implicit suggestion that declining progesterone explains feeling "completely unlike themselves" oversimplifies the complex hormonal changes of menopause, which involve multiple hormones, not just progesterone.